In a report published by ResearchAndMarkets.com, the global infection control surveillance solutions market is forecasted to undergo a considerable expansion in the next five years. Between 2023 and 2028, this industry is expected to more than double in size, with projected market value set to climb from $0.58 billion in 2023 to $1.23 billion by 2028. This showcases a robust compound annual growth rate (CAGR) of 13.47% during this period.
Several pivotal trends and growth drivers are understood to be behind this formidable expansion, making the infection control surveillance market a highly intriguing arena for both industry entities and investors. As a result, the infection control surveillance solutions market becomes an increasingly intriguing field for industry actors and investors alike.
The report analyses the market based on several factors, including the type of solutions provided, the type of infection, and the end-users. The geographical landscape was also reviewed, with North America leading the pack. Accounting for over 34% of the global share in 2023, the dominance is primarily due to the sophisticated healthcare system, extensive research funding, and considerable investments made across the healthcare industry present in this region.
In terms of competition, the industry presents a moderately fragmented state. Numerous international players offer a variety of infection control surveillance solutions. Despite the multitude of competitors, prominent vendors can be recognized, contributing significantly to the market’s vast landscape. This market analysis provides substantial information for key players and interested investors, answering essential questions about market dynamics, growth enablers, restraints, opportunities, and trends.
As we brace for the future, this report provides an invaluable guide and reference point to the inevitable growth and changes set to occur in the global infection control surveillance solutions market.